| Description of Property | Date Acquired | Cost or Other Basis | Prior Years' Depreciation | Computation Method | Rate / Life (# of years) |
Current Year's Depreciation Expense | Net Investment Income | Adjusted Net Income | Cost of Goods Sold Not Included |
|---|
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| AMERICAN GROWTH FD OF AMERICA | 124,933 | 195,015 |
| CAPITAL WORLD GROWTH & INCOME | 203,382 | 325,754 |
| PROSHARES TRUST | 1,232,459 | 550,875 |
| XENOPORT, INC. | 8,006 | 4,376 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| ENABLE INJECTIONS, LLC | 2,236,590 | ||
| NEURONETICS, INC. SER. D PFD | 125,000 | 28,689 | |
| NEURONETICS, INC. SER. E PFD | 300,000 | 93,389 | |
| NEURONETICS, INC. SER. F PFD | 814,097 | 824,771 | |
| PERCEPTIS MEDICAL SERIES A PRE | 506,692 | 506,691 | |
| SKYLINE VENTURE PARTNERS III, | 5,000 | ||
| SUREFIRE MEDICAL SERIES B-1 PR | 1,000,000 | 490,956 | |
| SUREFIRE MEDICAL SERIES B-2 PR | 1,500,000 | 1,255,814 | |
| SUREFIRE SERIES A PREFERRED ST | 805,000 | 244,531 | |
| SUREFIRE SERIES C1 PREFERRED S | 530,000 | 616,174 | |
| SUREFIRE SERIES C2 PREFERRED S | 930,148 | 1,035,852 | |
| USVP ENTREPRENEUR PARTNERS VII | 34,502 | 26,928 | |
| ZUREX PHARMA, INC SERIES A PRE | 200,000 | 59,786 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| General Consultations | 6,193 | 6,193 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Administrative Fees | 44,399 | 44,399 | ||
| Bank Charges | 30 | 30 | ||
| K-1 Exp ENABLE INJECTIONS, LLC | 1,389 | |||
| K-1 Exp USVP ENTREPRENEUR PART | 1,600 | 1,600 | ||
| State or Local Filing Fees | 61 | 61 | ||
| FOUNDATION DUES & MEMBERSHIPS | 10,000 | 10,000 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| K-1 Inc/Loss ENABLE INJECTIONS, LLC | -167,418 | -167,418 | |
| K-1 Inc/Loss SKYLINE VENTURE PARTNERS III, L.P. | 45 | 45 | |
| K-1 Inc/Loss USVP ENTREPRENEUR PARTNERS VIII-B, LP | 363 | 363 | |
| Federal Tax Refund | 5,519 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| PHILANTHROPIC CONSULTING FEES | 12,000 | 12,000 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| 990-PF Estimated Tax for 2015 | 19,600 |